Chandigarh (PRWEB) October 1, 2006
Grewal Eye Institute (GEI), the premier comprehensive Eye Care Institute based at Chandigarh, has achieved a new high in bringing the most recent technological advancement in the field of eye care, by becoming the initial and the only institute, not only in India, but in the entire Indian Sub-Continent to offer the revolutionary ‘Corneal Collagen Crosslinking with Riboflavin’ (C3R) Treatment to the masses.
The C3R process, the only known treatment that has lately been proven to permanently halt the progression of the dreaded Keratoconus disease, was commercially launched globally in the second week of this month itself. By procuring this when-in-a-decade technological break-via in much less than two weeks of its launch, GEI is now 1 of the few eye institutes in the world and the only in Indian subcontinent, to give comprehensive treatment now accessible for this previously untreatable disease. This was announced here right now by Dr. SPS Grewal, CEO, GEI.
The C3R Treatment is a ray of hope for lacs of Indian Keratoconus Patients, who, just before the launch of this advanced process, had been resigned to the vagaries of fate. This is simply because Keratoconus is amongst the most dreaded of eye diseases, as in most of the instances, the illness progresses relentlessly in the course of the young age, does not have any acute symptoms initially and thus is usually not detected in the early stages. In the advanced stages, the only treatment choices accessible earlier were surgical insertion of ‘Intacs’ or a ‘Corneal Transplant’, both of which have limited success on numerous grounds, like trauma to the eye, quite a few precautions needed post-surgery and a long recovery period etc. Most importantly, from both the doctors’ & patients’ perspective, neither of the operations guaranteed a stoppage of the illness. There was always the possibility of setting in of Keratoconus again, even soon after the operation. This produced the scenario a frustrating 1 for both the patient and the doctor.
Speaking at the press conference Dr S.P.S. Grewal, (CEO), GEI said, “C3R is a non-surgical process. Also it is the only identified process that is proven to halt the progression of the dreaded Keratoconus. This treatment now provides an end to a lifetime of waiting and uncertainty for Keratoconus patients. This is a straightforward one-time treatment that offers a permanent solution to Keratoconus. It does not require heavy precautions or standard follow-up visits, does not require an eye donor as necessary in ‘Corneal Transplant’, does not require any stitches or incision in the eye, takes just around one hour and the patient recovery is quick. This procedure is a boon for patients with keratoconus”.
Keratoconus weakens the cornea of the eye causing the eye to bulge outwards and producing moderate to severe blurriness of vision. In the C3R process, the eye is impregnated with a riboflavin remedy and exposed to ultra-high frequency light. C3R causes the collagen fibrils to thicken, stiffen, and crosslink & re-attach to each other, creating the cornea stronger and a lot more stable therefore convincingly halting the progression of the illness. This approach can also be utilized in corneal ulcers and before LASIK treatment in high Myopes to decrease the risk of postoperative Keratectasia.
Like all remedies, this process is most beneficial when performed at the earliest feasible stage of Keratoconus when the visual and mechanical damage to the cornea is minimal. This is where the role of contemporary topography devices such as the Pentacam lies. The Pentacam helps to detect Keratoconus much prior to it can be detected in a clinical examination and ensures that the illness is permanently halted by C3R before any serious damage to the eye.
The C3R process was launched internationally at the 24th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) held at London from September 9-13, 2006 where Dr SPS Grewal and team presented their research work on Pentacam.
Speaking at the press conference DR SPS Grewal said, “It is always our endeavour to bring the best, safest and the latest technologies & advancements in the field of eye care to patients in our region. We are quite happy to be the first and only institute in the Indian Sub-Continent to offer the C3R procedure. For the field of Opthhalmology the treatment of Keratoconus is as considerable as bypass surgery or angioplasty in cardiology.” ***
Keratoconus is a degenerative non-inflammatory disorder of the eye in which structural adjustments inside the cornea cause it to thin and change to a far more conical shape than its typical gradual curve. Keratoconus can cause substantial distortion of vision, with numerous images, streaking and sensitivity to light all often reported by the patient. Though regularly thought of as a rare condition, Keratoconus is the most common dystrophy of the cornea, affecting around one person in a thousand. It is typically diagnosed in the patient’s adolescent years and attains its most severe state in the twenties and thirties. The course of its progression following diagnosis is unpredictable. If in both eyes, the deterioration in vision linked with the disease can affect the person’s ability to drive a car or read normal print. Over 90% of patients have involvement of both eyes, though it is not unusual for there to be asymmetric modifications, with 1 eye becoming much more involved than the other.
The abnormal curvature of the cornea due to Keratoconus adjustments the cornea’s refractive error producing moderate to severe blurriness of vision. Keratoconus is an irregular protrusion of the cornea, the clear surface over the colored part of the eye. It is comparable, structurally, to the crystal of a watch. If this crystal or windowpane is not smooth, the light will not bend evenly and an irregular image will be formed, like searching by means of a bumpy piece of glass.
Adavantages of C3R:
Basic one time treatment
No periodic treatments needed
Halts the progress and causes some regression
It is permanent
No handling of lenses every day
Does not will need any eye donation
No precaution
No injection
No stitches as in Keratoplasty
No incisions as in Intacs
Fast recovery, short follow up.
For Further Info, Please Contact:
Dr. S. P. S. Grewal
(Former Associate Professor, Deptt. of Ophthalmology, PGIMER, Chandigarh)
Grewal Eye Institute
The Premiere Institute for complete Eye Care
(ISO 9001:2000 Certified)
SCO 168, Sector 9-C, Madhya Marg, Chandigarh-160009 (India)
Ph : +91-172-2747118, 5193969
Fax : +91-172-2744843
Site : http://www.lasikgei.com
###
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
0 comments:
Post a Comment